CVE-2014-0370
Unspecified vulnerability in the Siebel Life Sciences component in Oracle Siebel CRM 8.1.1 and 8...
Unspecified vulnerability in the Siebel Life Sciences component in Oracle Siebel CRM 8.1.1 and 8.2.2 allows remote authenticated users to affect availability via unknown vectors related to Clinical Trip Report.
Exploit likelihood
What each source reports
NVD Score used
Unspecified vulnerability in the Siebel Life Sciences component in Oracle Siebel CRM 8.1.1 and 8.2.2 allows remote authenticated users to affect availability via unknown vectors related to Clinical Trip Report.
- Record
CVE-2014-0370- CVSS 2.0
- 2.8 Low
AV:N/AC:M/Au:M/C:N/I:N/A:P - Updated
- 2026-11-02
CVE List No score
Unspecified vulnerability in the Siebel Life Sciences component in Oracle Siebel CRM 8.1.1 and 8.2.2 allows remote authenticated users to affect availability via unknown vectors related to Clinical Trip Report.
- Record
CVE-2014-0370- Updated
- 2026-11-02
EUVDEUVD-2014-0408 No score
Unspecified vulnerability in the Siebel Life Sciences component in Oracle Siebel CRM 8.1.1 and 8.2.2 allows remote authenticated users to affect availability via unknown vectors related to Clinical Trip Report.
- Record
EUVD-2014-0408- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-gg9m-hrh8-cvc3 No score
Unspecified vulnerability in the Siebel Life Sciences component in Oracle Siebel CRM 8.1.1 and 8...
Unspecified vulnerability in the Siebel Life Sciences component in Oracle Siebel CRM 8.1.1 and 8.2.2 allows remote authenticated users to affect availability via unknown vectors related to Clinical Trip Report.
- Record
GHSA-gg9m-hrh8-cvc3- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2014-0370 is a low vulnerability (CVSS 2.8) in Oracle Siebel Crm, published January 15, 2014. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.26%, the 69th percentile. No source names a fixed version.